Do you want to read an article? Please log in or register.
The 2021 WHO Classification of Lung Tumors: Impact of advances since 2015
Lung, Respiratory and Thoracic CancerCOVID-19
Related content
Head and Neck Cancer
The 2021 World Health Organization Classification of Tumors of the Thymus and Mediastinum: What's new in thymic epithelial, germ cell and mesenchymal tumors?
J Thorac Oncol
Marx A, Chan JKC, Chalabreysse L, Dacic S, Detterbeck F, French CA, Hornick JL, Inagaki H, Jain D, Lazar AJ, Marino M, Marom EM, Moreira AL, Nicholson AG, Noguchi M, Nonaka D, Papotti M, Porubsky S, Sholl LM, Tateyama H, Thomas de Montpréville V, Travis WD, Rajan A, Roden AC, Ströbel P
doi: 10.1016/j.jtho.2021.10.010
COMMENTED
Endocrine and Neuroendocrine Tumors (NET)Lung, Respiratory and Thoracic Cancer
New molecular classification of large cell neuroendocrine carcinoma and small cell lung carcinoma with potential therapeutic impacts
★ 1
Recommended and commented by
PD Dr Sara De Dosso, Faculty Member
Transl Lung Cancer Res.
Lantuejoul S, Fernandez-Cuesta L, Damiola F, Girard N, McLeer A
doi: 10.21037/tlcr-20-269.
SPECIAL REPORT
Lymphoma
ZUMA-1
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
Impact of subsequent immune checkpoint inhibitor treatment on overall survival with avelumab vs docetaxel in platinum-treated advanced NSCLC: Post hoc analyses from the phase 3 JAVELIN Lung 200 trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Lung Cancer
Park K, Özgüroğlu M, Vansteenkiste J, Spigel D, Yang JC, Bajars M, Ruisi M, Manitz J, Barlesi F
doi: 10.1016/j.lungcan.2021.01.026
RECOMMENDED
Lung, Respiratory and Thoracic Cancer
The role of surgery in the treatment of oligoprogression after systemic treatment for advanced non-small cell lung cancer
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Joosten PJM, de Langen AJ, van der Noort V, Monkhorst K, Klomp HM, Veenhof AAFA, Dickhoff C, Smit EF, Hartemink KJ
doi: 10.1016/j.lungcan.2021.09.019
Lung, Respiratory and Thoracic Cancer
Impaired Tumor-infiltrating T Cells in Patients with COPD Impacts Lung Cancer Response to PD-1 Blockade
Am J Respir Crit Care Med.
Biton J, Ouakrim H, Dechartres A, Alifano M, Mansuet-Lupo A, Si H, Halpin R, Creasy T, Bantsimba-Malanda C, Arrondeau J, Goldwasser F, Boudou-Rouquette P, Fournel L, Roche N, Burgel PR, Goc J, Devi-Marulkar P, Germain C, Dieu-Nosjean MC, Cremer I, Herbst R, Damotte D
doi: 10.1164/
Breast Cancer
Recent Developments in Metastatic Breast Cancer
healthbook TIMES Oncology Hematology
Lung, Respiratory and Thoracic Cancer
Prospective multi-center validation of the detection of ALK rearrangements of circulating tumor cells for non-invasive longitudinal management of patients with advanced non-small cell lung cancer
J Thorac Oncol
Ilie M, MaziÈres J, Chamorey E, Heeke S, Benzaquen J, Thamphya B, Boutros J, Tiotiu A, Fayada J, Cadrane J, Poudenx M, Moro-Sibilot D, Barlesi F, Thariat J, Clement-Duchene C, Tomasini P, Hofman V, Marquette CH, Hofman P, STALKLUNG01 Study Consortium Investigators.
doi: 10.1016/j.jtho.2021.01.1617
Lung Cancer
Molecular Diagnostic and Precision Medicine in Non-Small Cell Lung Cancer. An Update on the Treatment of the Most Important Actionable Oncogenic Driver Alterations.
1Department of Medical Oncology, University Hospital Basel, Basel, Switzerland.